Fig. 7

NRPa-308 inhibits 786-O cell migration velocity more efficiently than sunitinib. a Photographs of scratch assay on cell monolayers in different experimental conditions; untreated, treated by NRPa-308 and by sunitinib. b The effects of NRPa-308 and sunitinib on 786-O cell migration at different concentrations by quantifying the above-mentioned experiments. c NRPa-308 (2 μM) inhibited the invasion of collagen-coated Boyden chambers (Control (Ctrl) and NRPa-308-treated duplicates are shown). d Quantification of the results shown in (c). **p < 0.01; *** p < 0.001